Clinical Trial Update: A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled, double-blind trial evaluating KLH-2109 for endometriosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• KLH-2109

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED